Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Wing C Chan

Showing results (161-170 of 295) with videos related to

Pageof 30
Sort By:
The American Journal of Surgical Pathology|March 15, 2016
Clinicopathologic Characterization of Aggressive Natural Killer Cell Leukemia Involving Different Tissue SitesLi-Min Gao, Sha Zhao, Wei-Ping Liu, et al.
Journal of Cellular Biochemistry|January 14, 2010
Identification and functional relevance of de novo DNA methylation in cancerous B-cell populationsXiao-Ming Wang, Timothy C Greiner, Marina Bibikova, et al.
Blood|July 31, 2010
A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapyChristopher P Fox, Tracey A Haigh, Graham S Taylor, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 29, 2009
NCCN task force report: molecular markers in leukemias and lymphomasJerald P Radich, Andrew D Zelenetz, Wing C Chan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphomaChristine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
Cancer Research|July 19, 2017
CTLA4 Promotes Tyk2-STAT3-Dependent B-cell OncogenicityAndreas Herrmann, Christoph Lahtz, Toshikage Nagao, et al.
Blood|March 18, 2006
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survivalRobin A Roberts, George Wright, Andreas R Rosenwald, et al.
JAMA Surgery|February 22, 2023
Association Between Familiarity of the Surgeon-Anesthesiologist Dyad and Postoperative Patient Outcomes for Complex Gastrointestinal Cancer SurgeryJulie Hallet, Rinku Sutradhar, Angela Jerath, et al.
Human Pathology|May 8, 2021
Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphomaShweta Chaudhary, Noah Brown, Joo Y Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2008
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphomaKai Fu, Dennis D Weisenburger, William W L Choi, et al.
Pageof 30

Showing results (161-170 of 295) with videos related to

Sort By:
Pageof 30
The American Journal of Surgical Pathology|March 15, 2016
Clinicopathologic Characterization of Aggressive Natural Killer Cell Leukemia Involving Different Tissue SitesLi-Min Gao, Sha Zhao, Wei-Ping Liu, et al.
Journal of Cellular Biochemistry|January 14, 2010
Identification and functional relevance of de novo DNA methylation in cancerous B-cell populationsXiao-Ming Wang, Timothy C Greiner, Marina Bibikova, et al.
Blood|July 31, 2010
A novel latent membrane 2 transcript expressed in Epstein-Barr virus-positive NK- and T-cell lymphoproliferative disease encodes a target for cellular immunotherapyChristopher P Fox, Tracey A Haigh, Graham S Taylor, et al.
Journal of the National Comprehensive Cancer Network : JNCCN|July 29, 2009
NCCN task force report: molecular markers in leukemias and lymphomasJerald P Radich, Andrew D Zelenetz, Wing C Chan, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 28, 2005
Expression of PKC-beta or cyclin D2 predicts for inferior survival in diffuse large B-cell lymphomaChristine P Hans, Dennis D Weisenburger, Timothy C Greiner, et al.
Cancer Research|July 19, 2017
CTLA4 Promotes Tyk2-STAT3-Dependent B-cell OncogenicityAndreas Herrmann, Christoph Lahtz, Toshikage Nagao, et al.
Blood|March 18, 2006
Loss of major histocompatibility class II gene and protein expression in primary mediastinal large B-cell lymphoma is highly coordinated and related to poor patient survivalRobin A Roberts, George Wright, Andreas R Rosenwald, et al.
JAMA Surgery|February 22, 2023
Association Between Familiarity of the Surgeon-Anesthesiologist Dyad and Postoperative Patient Outcomes for Complex Gastrointestinal Cancer SurgeryJulie Hallet, Rinku Sutradhar, Angela Jerath, et al.
Human Pathology|May 8, 2021
Relative frequency and clinicopathologic characteristics of MYC-rearranged follicular lymphomaShweta Chaudhary, Noah Brown, Joo Y Song, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 30, 2008
Addition of rituximab to standard chemotherapy improves the survival of both the germinal center B-cell-like and non-germinal center B-cell-like subtypes of diffuse large B-cell lymphomaKai Fu, Dennis D Weisenburger, William W L Choi, et al.
Pageof 30